Day: September 16, 2019

Airlines
Apple
Auto Industry
Biopharmaceuticals
Biotech
Crude Oil
Daily Rundown
Defensive Stocks
Donald Trump
Energy Sector
Oil
Tech Stocks

Defense Stocks Are Soaring After Trump Says U.S. Is “Locked And Loaded” Following Oil Attack In Saudi Arabia

Plus, oil prices are surging, airline stocks are falling, GM union workers are striking, and Apple’s newest iPhones are beating demand expectations.

Read More
Biomedical
One Hot Stock
TradersPro Alerts

CEL-SCI Corporation (CVM) -Buy Target – $8.70 or better

Trade Setup Buy Target – $8.70 or better Sell Target – TradersPro Sell Signal CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and other diseases. The company’s lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of primary head and neck cancer. […]

Read More
Consumer Discretionary
Discretionary
Fibonacci Retracement
Fundamental Analysis
Leisure
Risk
Technical Analysis
Value Investing
Value Stocks

DRI is up 27.52% year to date – is it too expensive?

An eventful weekend promises to keep the market interesting this week. A series of drone strikes on Saturday knocked out about half of Saudi Arabia’s daily oil production. The culprit has yet to be definitely identified, although the Trump administration didn’t hesistate from pointing fingers at Iran. As of Sunday night, both Brent and West […]

Read More
© Copyright 2020 Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.